Metraipolis › archive › dc_a5d394cccf62

Synergistic efficacy and safety of PD-1/PD-L1 inhibitors combined with nab-paclitaxel and platinum chemotherapy in NSCLC: A systematic review and… — Europe PMC PMID:41415558

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41415558
DOI
10.3389/fonc.2025.1649777
License (as archived)
solo-consultazione
Archived
2026-11-08T00:02:12.269Z
SHA-256 of the archived text
f033d6e0ec565bb65d12649d5c5f1883e052223a4b9512f3fdbe28c9d367777a
Stable URL of this page
https://metraipolis.com/documento/dc_a5d394cccf62

How to cite

Synergistic efficacy and safety of PD-1/PD-L1 inhibitors combined with nab-paclitaxel and platinum chemotherapy in NSCLC: A systematic review and… — Europe PMC PMID:41415558 — Europe PMC (en), https://europepmc.org/article/MED/41415558 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5d394cccf62 (Metraipolis archive dc_a5d394cccf62, sha256 f033d6e0ec565bb65d12649d5c5f1883e052223a4b9512f3fdbe28c9d367777a)
BibTeX
@misc{dca5d394cccf62,
  title = {Synergistic efficacy and safety of PD-1/PD-L1 inhibitors combined with nab-paclitaxel and platinum chemotherapy in NSCLC: A systematic review and… — Europe PMC PMID:41415558},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41415558},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5d394cccf62; sha256 f033d6e0ec565bb65d12649d5c5f1883e052223a4b9512f3fdbe28c9d367777a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41415558. Agents can read the archived copy with the MCP tool read_document.